Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 Par Value Per Share
-
Shares outstanding
-
73.2M
-
Number of holders
-
31
-
Total shares
-
8.64M
-
Shares change
-
+58.3K
-
Total reported value, excl. options
-
$10.2M
-
Value change
-
+$62.5K
-
Number of buys
-
14
-
Number of sells
-
-10
-
Price
-
$1.18
Significant Holders of IN8BIO, INC. - Common Stock, $0.0001 Par Value Per Share (INAB) as of Q1 2024
31 filings reported holding INAB - IN8BIO, INC. - Common Stock, $0.0001 Par Value Per Share as of Q1 2024.
IN8BIO, INC. - Common Stock, $0.0001 Par Value Per Share (INAB) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.64M shares
of 73.2M outstanding shares and own 11.81% of the company stock.
Largest 10 shareholders include AIGH Capital Management LLC (2.87M shares), VANGUARD GROUP INC (1.42M shares), Ensign Peak Advisors, Inc (1.12M shares), 683 Capital Management, LLC (615K shares), Sigma Planning Corp (515K shares), Alyeska Investment Group, L.P. (446K shares), Voss Capital, LLC (323K shares), GEODE CAPITAL MANAGEMENT, LLC (281K shares), Stonegate Investment Group, LLC (180K shares), and Rock Creek Group, LP (151K shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.